KR102018209B1 - 위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법 - Google Patents

위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법 Download PDF

Info

Publication number
KR102018209B1
KR102018209B1 KR1020170093453A KR20170093453A KR102018209B1 KR 102018209 B1 KR102018209 B1 KR 102018209B1 KR 1020170093453 A KR1020170093453 A KR 1020170093453A KR 20170093453 A KR20170093453 A KR 20170093453A KR 102018209 B1 KR102018209 B1 KR 102018209B1
Authority
KR
South Korea
Prior art keywords
gastric cancer
egfr
rantes
ttr
apoa1
Prior art date
Application number
KR1020170093453A
Other languages
English (en)
Korean (ko)
Other versions
KR20190011358A (ko
Inventor
김철우
김용대
신용성
연은희
강경남
신호상
권오란
Original Assignee
(주) 바이오인프라생명과학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 바이오인프라생명과학 filed Critical (주) 바이오인프라생명과학
Priority to KR1020170093453A priority Critical patent/KR102018209B1/ko
Priority to CN201880061770.3A priority patent/CN111108390A/zh
Priority to PCT/KR2018/006527 priority patent/WO2019022370A1/ko
Publication of KR20190011358A publication Critical patent/KR20190011358A/ko
Application granted granted Critical
Publication of KR102018209B1 publication Critical patent/KR102018209B1/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020170093453A 2017-07-24 2017-07-24 위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법 KR102018209B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020170093453A KR102018209B1 (ko) 2017-07-24 2017-07-24 위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법
CN201880061770.3A CN111108390A (zh) 2017-07-24 2018-06-08 用于诊断胃癌的组合物和使用组合物进行诊断胃癌的方法
PCT/KR2018/006527 WO2019022370A1 (ko) 2017-07-24 2018-06-08 위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170093453A KR102018209B1 (ko) 2017-07-24 2017-07-24 위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법

Publications (2)

Publication Number Publication Date
KR20190011358A KR20190011358A (ko) 2019-02-07
KR102018209B1 true KR102018209B1 (ko) 2019-09-05

Family

ID=65040660

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170093453A KR102018209B1 (ko) 2017-07-24 2017-07-24 위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법

Country Status (3)

Country Link
KR (1) KR102018209B1 (zh)
CN (1) CN111108390A (zh)
WO (1) WO2019022370A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114350742A (zh) * 2021-12-21 2022-04-15 海南松林生物科技有限责任公司 一种胃癌检测标记物组合及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100679173B1 (ko) * 2006-02-28 2007-02-06 주식회사 바이오인프라 위암 진단용 단백질 마커 및 이를 이용한 진단키트
US20120028269A1 (en) * 2010-06-10 2012-02-02 National University Of Singapore Methods For Detection Of Gastric Cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102011A1 (en) * 2011-09-14 2013-04-25 Cleveland State University Human leucine-rich a-2-glycoprotein-1 and aminopeptidase n as risk indicators for cancer
KR101783994B1 (ko) * 2015-06-11 2017-11-07 사회복지법인 삼성생명공익재단 위암 진단방법 및 이를 이용한 위암 진단키트
CN106872704A (zh) * 2017-03-17 2017-06-20 中国科学院上海高等研究院 八种蛋白质用作鉴定浆膜层浸润深度胃癌的分子标记的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100679173B1 (ko) * 2006-02-28 2007-02-06 주식회사 바이오인프라 위암 진단용 단백질 마커 및 이를 이용한 진단키트
US20120028269A1 (en) * 2010-06-10 2012-02-02 National University Of Singapore Methods For Detection Of Gastric Cancer

Also Published As

Publication number Publication date
WO2019022370A1 (ko) 2019-01-31
CN111108390A (zh) 2020-05-05
KR20190011358A (ko) 2019-02-07

Similar Documents

Publication Publication Date Title
Rho et al. Protein and glycomic plasma markers for early detection of adenoma and colon cancer
KR101853118B1 (ko) 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
CN105755112B (zh) 结肠直肠癌的诊断
CN112362871B (zh) 食管癌的生物标志物及其应用
AU2012220896B2 (en) Biomarker panels, diagnostic methods and test kits for ovarian cancer
CN112345755B (zh) 乳腺癌的生物标志物及其应用
CN108351358B (zh) 肝癌测试方法
JP6328103B2 (ja) がんの予後判定および診断方法
US20140271621A1 (en) Methods of prognosis and diagnosis of pancreatic cancer
JP6829445B2 (ja) 肝細胞癌および膵臓がんを診断するためのラミニン２の使用
JP2019012077A (ja) 炎症性肝疾患の診断のための方法および組成物
KR102018205B1 (ko) 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
WO2016195051A1 (ja) 膵がんを診断するための血漿バイオマーカーパネル
JP4515099B2 (ja) Ｌａｓｐ−１免疫反応性の決定によって炎症性疾患および感染を診断するための方法
WO2015019979A1 (ja) 統合失調症に関するバイオマーカー
KR102018209B1 (ko) 위암 진단용 조성물 및 상기 조성물을 이용한 위암 진단 방법
JP5924502B2 (ja) リンパ球性漏斗下垂体後葉炎のバイオマーカー及びその用途
CN115372616A (zh) 胃癌相关的生物标志物及其应用
US20150004633A1 (en) Assays and methods for the diagnosis of ovarian cancer
JP2020519895A (ja) 多発性硬化症の進行を検出する、サブタイプ分類する、および／または評価するための、診断用バイオマーカー
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
KR102128251B1 (ko) 아르기닌이 메틸화된 drd2에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
US20230375550A1 (en) Method for diagnosing breast cancer by using biomarker
KR102136747B1 (ko) 장형 위암의 예후 진단 마커
KR20180026654A (ko) 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right